Brokerages expect Core Laboratories (NYSE:CLB) to announce earnings per share (EPS) of $0.35 for the current fiscal quarter, according to Zacks Investment Research. Three analysts have made estimates
Norges Bank purchased a new position in shares of Core Laboratories (NYSE:CLB) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC).
Core Laboratories (NYSE:CLB) is scheduled to release its earnings data after the market closes on Wednesday, April 22nd. Analysts expect Core Laboratories to post earnings of $0.37 per share for the q
Geode Capital Management LLC reduced its holdings in Core Laboratories (NYSE:CLB) by 0.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was

Earnings Heat Up And Gold On Display

01:04pm, Saturday, 18'th Apr 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
The Zacks Analyst Blog Highlights: Schlumberger, Halliburton, Core Laboratories, ProPetro and Oceaneering International
The Zacks Analyst Blog Highlights: Schlumberger, Halliburton, Core Laboratories, ProPetro and Oceaneering International
Shares of Core Laboratories (NYSE:CLB) have received a consensus rating of “Hold” from the seventeen ratings firms that are presently covering the stock, Marketbeat.com reports. Two research analy
RBC Capital analyst Kurt Hallead maintained a Buy rating on Core Laboratories (CLB) on April 14 and set a price target of $13.00. The company's shares
The oilfield service companies' Q1 earnings are likely to bear scars of activity slump on account of coronavirus-induced crude price plunge.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE